Oblivion Elixir Ltd 16001121 false 2024-10-07 2025-10-31 2025-10-31 The principal activity of the company is manufacture of energy drinks. Digita Accounts Production Advanced 6.30.9574.0 true true 16001121 2024-10-07 2025-10-31 16001121 2025-10-31 16001121 bus:OrdinaryShareClass1 2025-10-31 16001121 core:RetainedEarningsAccumulatedLosses 2025-10-31 16001121 core:ShareCapital 2025-10-31 16001121 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 16001121 core:PatentsTrademarksLicencesConcessionsSimilar 2025-10-31 16001121 bus:SmallEntities 2024-10-07 2025-10-31 16001121 bus:AuditExemptWithAccountantsReport 2024-10-07 2025-10-31 16001121 bus:FilletedAccounts 2024-10-07 2025-10-31 16001121 bus:SmallCompaniesRegimeForAccounts 2024-10-07 2025-10-31 16001121 bus:RegisteredOffice 2024-10-07 2025-10-31 16001121 bus:Director1 2024-10-07 2025-10-31 16001121 bus:OrdinaryShareClass1 2024-10-07 2025-10-31 16001121 bus:PrivateLimitedCompanyLtd 2024-10-07 2025-10-31 16001121 core:RetainedEarningsAccumulatedLosses 2024-10-07 2025-10-31 16001121 core:ShareCapital 2024-10-07 2025-10-31 16001121 core:PatentsTrademarksLicencesConcessionsSimilar 2024-10-07 2025-10-31 16001121 countries:UnitedKingdom 2024-10-07 2025-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 16001121

Oblivion Elixir Ltd

Annual Report and Unaudited Financial Statements

for the Period from 7 October 2024 to 31 October 2025

 

Oblivion Elixir Ltd

Company Information

Director

Miss Malika Bagai

Registered office

9 Berners Place
London
United Kingdom
W1T 3AD

 

Oblivion Elixir Ltd

(Registration number: 16001121)
Balance Sheet as at 31 October 2025

Note

2025
£

Fixed assets

 

Intangible assets

4

3,282

Current assets

 

Cash at bank and in hand

 

104

Creditors: Amounts falling due within one year

5

(24,070)

Net current liabilities

 

(23,966)

Net liabilities

 

(20,684)

Capital and reserves

 

Called up share capital

1

Retained earnings

(20,685)

Shareholders' deficit

 

(20,684)

Director's responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

•

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 1 October 2026
 

.........................................
Miss Malika Bagai
Director

For the financial period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

 

Oblivion Elixir Ltd

Statement of Changes in Equity for the Period from 7 October 2024 to 31 October 2025

Share capital
£

Retained earnings
£

Total
£

Loss for the year

-

(20,685)

(20,685)

New share capital subscribed

1

-

1

At 31 October 2025

1

(20,685)

(20,684)

 

Oblivion Elixir Ltd

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
9 Berners Place
London
W1T 3AD
United Kingdom

These financial statements were authorised for issue by the director on 1 October 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis, with management having given due consideration to the company’s ability to continue as a going concern for at least the next twelve months.

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Trademarks, patents and licenses

10 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Oblivion Elixir Ltd

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

 

Oblivion Elixir Ltd

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

4

Intangible assets

Trademarks, patents and licenses
 £

Total
£

Cost or valuation

Additions

3,647

3,647

At 31 October 2025

3,647

3,647

Amortisation

Amortisation charge

365

365

At 31 October 2025

365

365

Carrying amount

At 31 October 2025

3,282

3,282

5

Creditors

Creditors: amounts falling due within one year

2025
£

Due within one year

Accruals and deferred income

480

Director loan account

23,590

24,070

6

Share capital

Allotted, called up and fully paid shares

2025

No.

£

Ordinary of £1 each

1

1